Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Everolimus|DRUG: Exemestane|DRUG: Tamoxifen|DRUG: Fulvestrant|DRUG: Anastrozole|DRUG: Letrozole|DRUG: Toremifine
Sponsor: SCRI Development Innovations, LLC
Collaborators: Novartis